NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/20/2026
Back to search
Official data from USPTO
CDP CARDURION PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
12
Latest update
01/20/2026
Trademark type
Combined
Nice classes
42
Filing date
05/23/2025
Registration date
01/20/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/20/2026
Last transaction
01/20/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
08/01/2017
First use in commerce
08/01/2018
Drawing code
3
Owner type
03
Owner location
Burlington, MA, US
Examiner
KRUSSMAN,IAN GEORGE
Law office
N80
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the words "CARDURION" and "PHARMA" stacked to the right of a stylized heart-shaped design made up of the lower case letters c, d, and p, with the c and p shown mirrored.
Holders and representatives
Holders
Cardurion Pharmaceuticals, Inc.
Representatives
Valerie Brennan Plave Koch PLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development in the pharmaceutical field; conducting clinical trials for others in the field of cardiovascular medicine
Publications
History of USPTO decisions and trademark events.
12 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/20/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/02/2025
PUBO
PUBLISHED FOR OPPOSITION
12/02/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/26/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/04/2025
DOCK
ASSIGNED TO EXAMINER
11/03/2025
DOCK
ASSIGNED TO EXAMINER
10/09/2025
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/30/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/30/2025
MAFR
APPLICATION FILING RECEIPT MAILED
05/23/2025
NWAP
NEW APPLICATION ENTERED
05/23/2025
Continuous trademark protection
Get notified about every new filing that threatens CDP CARDURION PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.